We are live on ! Find out more
TI

Turner Investments Portfolio holdings

AUM $134K
1-Year Est. Return 49.03%
This Fund
S&P 500
This Quarter Est. Return
+10.67%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
AUM
$547M
AUM Growth
-$9.74M
Cap. Flow
-$42M
Cap. Flow %
-7.68%
Top 10 Hldgs %
16.06%
Holding
480
New
78
Increased
86
Reduced
74
Closed
239

Top Buys

Rank Stock Value
1
VFC icon
VF Corp
VFC
+$5.76M
2
ACHN
Achillion Pharmaceuticals
ACHN
+$5.22M
3
COR icon
Cencora
COR
+$4.35M
4
NFLX icon
Netflix
NFLX
+$4.25M
5
SBUX icon
Starbucks
SBUX
+$3.8M

Sector Composition

Rank Sector Weight
1 Healthcare 29.46%
2 Technology 20.64%
3 Consumer Discretionary 10.94%
4 Financials 9.21%
5 Industrials 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DWRE
51
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
$3.44M 0.63%
48,320
+12,310
+34% +$793K
AXON
52
Axon Enterprise
AXON
$46.1B
$3.27M 0.6%
98,110
+22,580
+30% +$706K
DIS icon
53
Walt Disney
DIS
$170B
$3.24M 0.59%
28,420
+4,540
+19% +$499K
SFS
54
DELISTED
Smart & Final Stores, Inc.
SFS
$3.11M 0.57%
174,050
+88,510
+103% +$1.57M
ESNT icon
55
Essent Group
ESNT
$6.16B
$3.1M 0.57%
113,410
+62,770
+124% +$1.61M
LNKD
56
DELISTED
LinkedIn Corporation
LNKD
$3.02M 0.55%
14,630
-12,630
-46% -$2.82M
MEOH icon
57
Methanex
MEOH
$4.19B
$3.02M 0.55%
54,190
-20,940
-28% -$1.18M
WDAY icon
58
Workday
WDAY
$41.1B
$2.99M 0.55%
39,162
-13,420
-26% -$1.14M
RGEN icon
59
Repligen
RGEN
$8.22B
$2.97M 0.54%
72,070
-26,370
-27% -$966K
PRAH
60
DELISTED
PRA Health Sciences, Inc.
PRAH
$2.97M 0.54%
+81,800
New +$2.59M
MNDT
61
DELISTED
Mandiant, Inc. Common Stock
MNDT
$2.97M 0.54%
+60,650
New +$2.75M
COO icon
62
Cooper Companies
COO
$14.4B
$2.94M 0.54%
66,120
-10,000
-13% -$451K
MJN
63
DELISTED
Mead Johnson Nutrition Company
MJN
$2.93M 0.54%
32,440
-26,290
-45% -$2.54M
TLGT
64
DELISTED
Teligent, Inc
TLGT
$2.91M 0.53%
46,195
-22,414
-33% -$1.52M
LAD icon
65
Lithia Motors
LAD
$8.37B
$2.88M 0.53%
25,450
+3,660
+17% +$390K
LGND icon
66
Ligand Pharmaceuticals
LGND
$5.82B
$2.83M 0.52%
+44,964
New +$2.45M
IPHI
67
DELISTED
INPHI CORPORATION
IPHI
$2.75M 0.5%
120,190
+32,020
+36% +$711K
AMPH icon
68
Amphastar Pharmaceuticals
AMPH
$883M
$2.73M 0.5%
155,280
+29,460
+23% +$459K
RRGB icon
69
Red Robin
RRGB
$148M
$2.72M 0.5%
+31,710
New +$2.61M
PTEN icon
70
Patterson-UTI
PTEN
$3.87B
$2.68M 0.49%
+142,600
New +$2.96M
HQY icon
71
HealthEquity
HQY
$8.73B
$2.67M 0.49%
83,390
+14,810
+22% +$398K
CRTO icon
72
Criteo S.A. Ordinary Shares
CRTO
$1.08B
$2.63M 0.48%
55,260
-23,720
-30% -$1.08M
ACHC icon
73
Acadia Healthcare
ACHC
$2.82B
$2.63M 0.48%
33,510
+9,780
+41% +$704K
ZOES
74
DELISTED
Zoe's Kitchen, Inc.
ZOES
$2.59M 0.47%
63,210
-47,780
-43% -$1.67M
AVNT icon
75
Avient
AVNT
$3.4B
$2.57M 0.47%
65,610
-15,030
-19% -$587K

Similar funds

Turner Investments's Q2 2015 Portfolio in Review

As of Q2 2015, Turner Investments held 480 positions worth $547M, down 1.8% from $556M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Turner Investments withdrew a net $42M in Q2 2015, closing 239 positions and reducing 74 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $5.47M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Turner Investments opened a new position in VF Corp worth $5.6M.

  • Turner Investments's largest Q2 2015 buy was VF Corp: 85,226 shares worth $5.6M.
  • Turner Investments added most to Cencora in Q2 2015, an estimated $4.35M increase.
  • Turner Investments's biggest Q2 2015 reduction was Ambarella, cutting an estimated $3.62M.
  • Turner Investments fully exited Alexion Pharmaceuticals in Q2 2015, selling an estimated $5.47M.
  • Turner Investments's ten largest holdings make up 16% of its $547M portfolio in Q2 2015.
  • Turner Investments opened 78 new positions and closed 239 in Q2 2015.
  • Turner Investments's portfolio value fell 1.8% quarter-over-quarter to $547M.

Based on Turner Investments's 13F filing for Q2 2015, filed 12 Aug 2015.